Brody, Marvin – Trademark Portfolio

Entity Type: 01

Brody, Marvin holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 6 filings in this category. The portfolio also extends into Class 8 (Hand Tools) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DR. BRODY'S. The owner is based in Brooklyn, NY.

#1C

3215 Ave. H

Brooklyn, NY 11210

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Brody, Marvin's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (6 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

8
Hand Tools (1 filing)

Hand tools and implements (hand-operated); cutlery; side arms; razors

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Brody, Marvin have?

Brody, Marvin has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 2 cancelled.

What trademark classes does Brody, Marvin file in?

Brody, Marvin files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 8 (Hand Tools), Class 14 (Jewelry). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Brody, Marvin's most well-known trademarks?

Brody, Marvin's registered trademark portfolio includes well-known marks such as DR. BRODY'S. These are among 1 currently registered trademark in the portfolio.

What is Brody, Marvin's trademark registration success rate?

Brody, Marvin has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.